<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Asthma Respiratory diseases Cough Wheeze Damp Bronchodilator House dust mite Atopy Allergy Pulmonology Medicine Respiratory therapy |
| UConn IPM Curriculum for Grades 7 & 8DocID: 1p5rp - View Document |
| Safety and Tolerability of Escalating Doses of House Dust Mite- Peptide Antigen Desensitization (HDM-PAD)DocID: 1oNzm - View Document |
| ORIGINAL ARTICLES AAEM Ann Agric Environ Med 1997, 4, 253–261 SEASONAL DYNAMICS OF HOUSE DUST MITE POPULATONS IN BED/MATTRESSDocID: 1gEJj - View Document |
| Anergis Appoints Kim Simonsen as Chief Development Officer − Senior Biotech Executive brings over 25 years of drug development expertise EPALINGES, Switzerland, June 2, 2015 – Anergis, a company developing novel andDocID: 1gmYG - View Document |
| Microsoft Word - About Eye Allergies.docxDocID: 1fX51 - View Document |